Edition:
United Kingdom

Resmed Inc (RMD.N)

RMD.N on New York Stock Exchange

112.93USD
14 Dec 2018
Change (% chg)

$-2.40 (-2.08%)
Prev Close
$115.33
Open
$114.02
Day's High
$114.02
Day's Low
$112.19
Volume
232,497
Avg. Vol
199,330
52-wk High
$116.61
52-wk Low
$83.88

Latest Key Developments (Source: Significant Developments)

Propeller Health To Be Acquired By ResMed For $225 Million
Monday, 3 Dec 2018 

Dec 3 (Reuters) - Safeguard Scientifics Inc::SAFEGUARD SCIENTIFICS PARTNER COMPANY PROPELLER HEALTH TO BE ACQUIRED FOR $225 MILLION BY RESMED.SAFEGUARD SCIENTIFICS - EXPECTS TO RECEIVE CASH PROCEEDS OF $41.4 MILLION.  Full Article

Resmed Inc Announces Results For The Q1 2019
Thursday, 25 Oct 2018 

Oct 25 (Reuters) - Resmed Inc ::. ANNOUNCES RESULTS FOR THE FIRST QUARTER OF FISCAL YEAR 2019.Q1 NON-GAAP EARNINGS PER SHARE $0.81.Q1 GAAP EARNINGS PER SHARE $0.73.Q1 REVENUE $588.3 MILLION VERSUS I/B/E/S VIEW $571.3 MILLION.Q1 EARNINGS PER SHARE VIEW $0.79 -- THOMSON REUTERS I/B/E/S.  Full Article

ResMed Wins German Patent Infringement Case Against Fisher & Paykel
Monday, 22 Oct 2018 

Oct 22 (Reuters) - ResMed Inc ::RESMED WINS GERMAN PATENT INFRINGEMENT CASE AGAINST FISHER & PAYKEL.COURT FINDS HEADGEAR USED ON SIMPLUS AND ESON 2 CPAP MASKS INFRINGES RESMED PATENT.  Full Article

Resmed Inc Says CEO Michael Farrell's FY 2018 Total Compensation Was $9.1 Mln
Wednesday, 3 Oct 2018 

Oct 3 (Reuters) - Resmed Inc ::RESMED INC SAYS CEO MICHAEL FARRELL'S FY 2018 TOTAL COMPENSATION WAS $9.1 MILLION VERSUS $8.1 MILLION IN FY 2017 - SEC FILING.RESMED INC SAYS PRESIDENT AND COO ROB DOUGLAS' FY 2018 TOTAL COMPENSATION WAS $6.2 MILLION VERSUS $5.8 MILLION IN FY 2017.  Full Article

Resmed Q4 Non-GAAP Earnings Per Share $0.95
Thursday, 2 Aug 2018 

Resmed Inc ::. ANNOUNCES RESULTS FOR THE FOURTH QUARTER OF FISCAL YEAR 2018.Q4 NON-GAAP EARNINGS PER SHARE $0.95.Q4 GAAP EARNINGS PER SHARE $0.76.Q4 REVENUE $623.6 MILLION VERSUS I/B/E/S VIEW $623.2 MILLION.Q4 EARNINGS PER SHARE VIEW $0.95 -- THOMSON REUTERS I/B/E/S.QUARTERLY DIVIDEND INCREASED BY 6% TO $0.37 PER SHARE.  Full Article

Resmed, Verily To Form Joint Venture To Help Reach Millions Of Untreated Sleep Apnea Sufferers
Wednesday, 11 Jul 2018 

July 11 (Reuters) - Resmed Inc ::RESMED, VERILY TO FORM JOINT VENTURE TO HELP REACH MILLIONS OF UNTREATED SLEEP APNEA SUFFERERS.RESMED INC - JOINT VENTURE WILL OPERATE AS A SEPARATE VENTURE FROM RESMED AND VERILY.RESMED - CO, VERILY, AN ALPHABET COMPANY, ANNOUNCED AGREEMENT TO FORM NEW JV.  Full Article

Resmed Inc To Acquire Healthcarefirst
Tuesday, 29 May 2018 

May 29 (Reuters) - Resmed Inc ::RESMED TO ACQUIRE HEALTHCAREFIRST, A CLOUD-BASED SOFTWARE AND SERVICES PROVIDER FOR HOME HEALTH AND HOSPICE AGENCIES.RESMED INC - TRANSACTION'S FINANCIAL TERMS WERE NOT DISCLOSED.  Full Article

Fisher & Paykel Healthcare Corporation ‍says wins patent case against ResMed in UK court​
Sunday, 12 Nov 2017 

Nov 13 (Reuters) - Fisher & Paykel Healthcare Corporation Ltd :‍Wins patent case against ResMed in UK court.Patent found invalid, ‍subject to appeal, European patent will be revoked in UK​.  Full Article

Resmed Inc reports Q1 earnings $0.60/shr
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Resmed Inc :Resmed Inc. Announces results for the first quarter of fiscal year 2018.Q1 GAAP earnings per share $0.60.Q1 revenue $523.7 million versus I/B/E/S view $505.6 million.Q1 earnings per share view $0.66 -- Thomson Reuters I/B/E/S.  Full Article

RESMED WINS GERMAN PATENT INFRINGEMENT CASE BROUGHT BY FISHER & PAYKEL
Thursday, 12 Oct 2017 

Oct 12 (Reuters) - Resmed Inc ::RESMED WINS GERMAN PATENT INFRINGEMENT CASE BROUGHT BY FISHER & PAYKEL.MUNICH DISTRICT COURT DECIDED CO'S AIRSENSE 10, AIRCURVE 10, LUMIS AND HUMIDIFIERS DO NOT INFRINGE FISHER & PAYKEL GERMAN UTILITY MODEL​.‍RULING IN GERMANY HAS NO IMPACT ON RESMED, FISHER & PAYKEL'S PATENT INFRINGEMENT LITIGATION IN OTHER JURISDICTIONS​.  Full Article